TABLE 3.
Summary of sex differences in highlighted nicotine behavioral studies.
Behavior | Animal | Result | References |
Chronic nicotine 2-bottle choice | C57BL/6J mice | ↑ nicotine consumption in females | O’Rourke et al., 2016; Bagdas et al., 2019 |
DBA/2J mice | |||
α7 KO mice | ↓ consumption in female KO. ↑ consumption in male KO. | Bagdas et al., 2019 | |
α6 KO, β2 KO mice | ↓ consumption in KO mice, no effect of sex. | ||
IVSA | Rat, multiple strains | ↑ nicotine SA in females vs. males (meta-analysis). | Flores et al., 2019 |
Sprague-Dawley rat | n.d. in earned infusions, lever presses. ↑ SA acquisition on FR schedule in females. ↑ breakpoints in females in PR schedule. | Donny et al., 2000 | |
Sprague-Dawley rat | ↑ SA in males vs. females | Leyrer-Jackson et al., 2020 | |
Long–Evans rat | n.d. in SA | ||
Wistar rat | ↓ SA in OVX females, restored to intact levels with E2. | Flores et al., 2016 | |
Adolescent Sprague-Dawley rat | Males: ↓ SA in adulthood. Females: n.d. in SA in adulthood | Levin et al., 2003, 2007 | |
Precipitated withdrawal: somatic | Wistar rat | n.d. in somatic withdrawal signs | Correa et al., 2019 |
Wistar rat | ↑ somatic withdrawal signs in males. | Tan et al., 2019 | |
Precipitated withdrawal: EPM | Wistar rat | ↑ in females vs. males | Correa et al., 2019; Flores et al., 2020 |
Wistar rat, OVX | ↑ with E2 supplementation, ↓ with progesterone supplementation. | Flores et al., 2020 | |
Spontaneous withdrawal: EPM | Wistar rat | ↑ in females vs. males, n.d. following OVX. | Torres et al., 2014 |
IVSA, intravenous self-administration; SA, self-administration; FR, fixed ratio; PR, progressive ratio; OVX, ovariectomy; EPM, elevated plus maze; E2, estradiol; n.d., no difference.